Effects and Mechanisms of Sensory Afferent Electrostimulation on Upper Limb Function in Patients With Hemiparesis

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Jul 30, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new therapy called Sensory Afferent Electrostimulation (SAES) to see if it helps improve arm function in children with hemiparesis, which means they have weakness on one side of their body. The trial will last for 5 weeks and will involve participants doing a special training program at home for about 30 minutes a day, five days a week, while also receiving regular occupational therapy. Researchers want to find out if this new therapy is more effective than just the usual therapy alone.

To participate, children must have a diagnosis of hemiparesis and some difficulties using their affected arm. Parents or guardians will need to give written permission for their child to join the study. There are some restrictions, such as not having certain medical treatments or surgeries recently. Throughout the trial, researchers will carefully monitor the children’s progress using advanced techniques to ensure they are getting the best possible care. This study is an exciting opportunity for young patients to potentially improve their arm function and overall quality of life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of hemiparesis
• • Upper limb deficits.
• • Written informed consent by participant and / or parent.
• Exclusion criteria:
• • Botulinum toxin injections in the last 6 months
• • Hand surgery in the last 2 years
• • UL trauma in the last year, medical conditions preventing UL training
• • Participation in another UL training.
• • For children who additionally undergo MRI and TMS measurements, the exclusion criteria contain MRI or TMS or contraindications such as implanted metal and an active epilepsy.